این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Biotechnology، جلد ۲۳، شماره ۴، صفحات ۸۹-۱۰۱
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Single-cell RNA-seq dissects specific marker in glioblastoma based on gene regulatory networks
چکیده انگلیسی مقاله Background: Glioblastoma (GBM) is one of the most aggressive and common tumors of the central nervous system (CNS),distinguished by its significant intratumoral heterogeneity and poor prognosis, with a median overall survival of approximately 15 months. Recent advances in single-cell RNA sequencing (scRNA-seq) have provided deeper insights into the molecular subtypes and heterogeneity of GBM, which include the proneural (PN), classical (CL), and mesenchymal (MES) subtypes.

Objectives: This study hypothesizes that constructing gene regulatory networks (GRNs) using single-cell RNA sequencing (scRNA-seq) data can elucidate the complex regulatory mechanisms underlying glioblastoma (GBM) heterogeneity. The primary aim is to identify key regulators and subtype-specific markers in GBM through the integration of scRNA-seq and GRNs, with the ultimate goal of discovering novel prognostic biomarkers that can improve patient stratification and treatment outcomes.

Methods: Malignant cells were identified based on inferred copy number variations (CNVs) from scRNA-seq data. Consensus clustering of expression profiles was used to assign GBM subtypes. Analyses of differential gene expression, ligand-receptor interactions, pathway activities, and responses to immune checkpoint inhibitors were conducted. GRNs were constructed by retaining co-expressed transcription factor (TF)-gene pairs with enriched transcription-binding motifs. Bulk RNA-seq data were then used to validate marker expression and assess prognostic value.

Results: Distinct functional roles and molecular characteristics were observed across GBM subtypes. Subtype-specific GRNs revealed both unique and shared regulatory features. GATA3 emerged as a potential prognostic marker, showing correlation with homologous recombination deficiency (HRD) and patient outcomes.

Conclusions: Subtype-resolved GRN analysis of GBM provides valuable insights into intratumoral heterogeneity and regulatory mechanisms. GATA3 may serve as a novel biomarker for prognosis and therapeutic stratification in GBM patients.
کلیدواژه‌های انگلیسی مقاله Glioblastoma,CNVs inference,Gene Regulatory Networks,single cell subtype,heterogeneity
نویسندگان مقاله Shenglan Li |
Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100071, China.

Yanjie Lan |
Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100071, China.

Jiachen Wang |
Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100071, China.

Zhuang Kang |
Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100071, China.

Mengqian Huang |
Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100071, China.

Rong Zhang |
Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100071, China.

Wenbin Li |
beijing tiantan hospital

نشانی اینترنتی https://www.ijbiotech.com/article_229906_69202ac029e20a12c1d8ae9a2c80b227.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات